(3R)-3-Methylpyrrolidin-3-ol hydrochloride, 95+%, 10g

Ethyl 4-(2-aminoethyl)benzoate hydrochloride, 98%, 1g

6-ethyl-3-(prop-2-yn-1-yl)benzo[d]thiazol-2(3H)-imine hydrobromide, 95.0%, 1g

2-(4-(Chloromethyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 5g

8-Bromo-4-chloro-7-methoxy-1,6-naphthyridine, 95.0%, 500mg

3-(3-(Cyclopentylthio)-5-(((2-methyl-4'-(methylsulfonyl)-[1,1'-biphenyl]-4-yl)oxy)methyl)-4H-1,2,4-triazol-4-yl)pyridine, 98%, 100mg

4-(Benzyloxy)benzenesulfonyl chloride, 97.0%, 25g

(3,4-Dimethoxyphenyl)hydrazine hydrochloride, 95%, 100mg

3-Bromo-5-(tert-butyl)benzo[b]thiophene, 98%, 25g

METHYL 4-AMINO-2,5-DIFLUOROBENZOATE, 95.0%, 1g

BioBlue.Lab BB.1153-PL Triocular with 4x/10x/S40x/S100x plan objectives and Rackless cross stage

(2-(Methylthio)pyrimidin-4-yl)methanol, 95.0%, 10g

4-Fluoroisoindoline-1,3-dione, 92.0%, 10g